• KemPharm Receives of Two Additional U.S. Patents americanpharmaceuticalreview
    August 04, 2020
    KemPharm announced the United States Patent and Trademark Office (USPTO) has recently issued two new patents to KemPharm governing methods of use and composition of matter for methylphenidate-based prodrugs.
PharmaSources Customer Service